RHOB and cancer: In the context of cancer, CCL24 expression has been shown to associate with poor prognosis in colorectal cancer and also contribute to hepatocellular carcinoma malignancy via the RhoB-VEGFA-VEGFR2 angiogenesis pathway (53, 54).